Cigna
About: Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
Employees: 72,500
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
57% more first-time investments, than exits
New positions opened: 138 | Existing positions closed: 88
28% more call options, than puts
Call options by funds: $1.2B | Put options by funds: $937M
17% more funds holding in top 10
Funds holding in top 10: 29 [Q2] → 34 (+5) [Q3]
2% more funds holding
Funds holding: 1,635 [Q2] → 1,662 (+27) [Q3]
3% more repeat investments, than reductions
Existing positions increased: 608 | Existing positions reduced: 592
0% more capital invested
Capital invested by funds: $83.7B [Q2] → $83.9B (+$238M) [Q3]
2.31% less ownership
Funds ownership: 89.14% [Q2] → 86.83% (-2.31%) [Q3]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$377
31%
upside
Avg. target
$398
38%
upside
High target
$420
46%
upside
7 analyst ratings
7 positive
100%
0 neutral
0%
0 negative
0%
Truist Securities David Macdonald 57% 1-year accuracy 55 / 96 met price target | 35%upside $390 | Buy Maintained | 6 Jan 2025 |
Piper Sandler Jessica Tassan 25% 1-year accuracy 5 / 20 met price target | 37%upside $394 | Overweight Reiterated | 5 Nov 2024 |
Barclays Andrew Mok 30% 1-year accuracy 19 / 63 met price target | 46%upside $420 | Overweight Maintained | 5 Nov 2024 |
Deutsche Bank George Hill 60% 1-year accuracy 6 / 10 met price target | 37%upside $394 | Buy Maintained | 4 Nov 2024 |
Stephens & Co. Scott Fidel 56% 1-year accuracy 22 / 39 met price target | 42%upside $410 | Overweight Reiterated | 1 Nov 2024 |
Financial journalist opinion
Based on 16 articles about CI published over the past 30 days
Positive
Seeking Alpha
3 days ago
Cigna: Buy The Drop On This Undervalued Growth Stock
Cigna's current valuation presents a compelling opportunity, trading at a forward PE of 9.9, significantly below its historical average of 12.0x. The company carries diversified revenue streams and consistent earnings growth, with Healthcare and Evernorth divisions driving strong performance and a 13% EPS CAGR over 10 years. Management targets 10-14% long-term annual EPS growth, supported by increased biosimilar adoption, behavioral health services growth, and aggressive share buybacks.
Negative
Seeking Alpha
5 days ago
Focus On Costs, Regulatory Outlook For Health Insurers In Q4'24 Earnings Season
Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth quarter of 2024, according to S&P Global Market Intelligence analysis of sell-side analyst forecasts. Coming off a challenging end to 2024, the upcoming earnings season is an opportunity for managed care companies to focus on 2025 expectations and Medicare Advantage growth, according to J.P. Morgan analyst Lisa Gill. UnitedHealth and Oscar Health are expected to log sequential and year-over-year revenue growth.
Negative
Zacks Investment Research
6 days ago
FTC Report Reveals PBM Practices Impacting Competition and Drug Costs
The report comes at a time when insurers are grappling with rising medical costs.
Neutral
PRNewsWire
1 week ago
The Cigna Group's Fourth Quarter 2024 Earnings Release Details
BLOOMFIELD, Conn. , Jan. 14, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a conference call the same day.
Neutral
PRNewsWire
1 week ago
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility and family-building services accessible and equitable for more employers.
Positive
24/7 Wall Street
1 week ago
Raymond James Analysts' Best Picks Could Explode Again in 2025: 4 Red-Hot Dividend Stocks
As the calendar turns to 2025, the leading Wall Street firms are releasing their top stock picks for the new year.
Positive
Seeking Alpha
1 week ago
Market Madness: 3 Blue-Chip Dividend Steals You Can't Ignore
The U.S. economy added 256,000 jobs last month, far exceeding expectations, which suggests a strong economy but reduces the likelihood of further Fed rate cuts. Rising long-term rates increase borrowing costs and competition for stocks, negatively impacting rate-sensitive sectors like utilities, real estate, and consumer staples. Despite a challenging market environment, equities still offer value, particularly in high-quality blue-chip stocks.
Positive
CNBC
1 week ago
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Employers are increasingly requiring workers on GLP-1 medications to enroll in nutrition and lifestyle coaching programs. Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.
Neutral
PRNewsWire
1 week ago
The Cigna Group Foundation Supports Mental Health and Housing Stability for Veterans, Announcing First Round of Grant Recipients
BLOOMFIELD, Conn. , Jan. 8, 2025 /PRNewswire/ -- The Cigna Group Foundation announced today 22 recipients for the first year of its new grant program that aims to improve veteran mental health with a focus on housing stability.
Neutral
Zacks Investment Research
2 weeks ago
Cigna Stock Plunges 18.7% in 3 Months: Should You Buy, Hold or Sell?
Despite market challenges, CI's strong fundamentals and growth drivers make it worth holding for long-term investors looking to capitalize on future recovery opportunities.
Charts implemented using Lightweight Charts™